Cardiff Park Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.03M Buy
889
+33
+4% +$38.9K 0.07% 117
2026
Q2
$1.03M Buy
856
+21
+3% +$21.5K 0.08% 112
2026
Q1
$768K Buy
835
+14
+2% +$14.2K 0.06% 141
2025
Q4
$882K Hold
821
– – 0.07% 131
2025
Q3
$626K Hold
821
– – 0.05% 161
2025
Q2
$640K Hold
821
– – 0.06% 146
2025
Q1
$678K Hold
821
– – 0.07% 135
2024
Q4
$634K Hold
821
– – 0.06% 138
2024
Q3
$727K Sell
821
-22
-3% -$19.8K 0.07% 127
2024
Q2
$763K Hold
843
– – 0.07% 119
2024
Q1
$656K Hold
843
– – 0.06% 137
2023
Q4
$491K Hold
843
– – 0.05% 152
2023
Q3
$453K Hold
843
– – 0.06% 151
2023
Q2
$395K Hold
843
– – 0.05% 167
2023
Q1
$290K Hold
843
– – 0.04% 188
2022
Q4
$308K Sell
843
-4
-0.5% -$1.42K 0.04% 192
2022
Q3
$274K Buy
+847
New +$268K 0.04% 197

Other funds holding LLY

Cardiff Park Advisors's LLY Position: Q3 2026 in Review

Cardiff Park Advisors increased its Eli Lilly (LLY) stake by 3.9% in Q3 2026, buying an estimated $38.9K and bringing the position to 889 shares worth $1.03M. The position accounts for 0.07% of the portfolio, ranked #117.

Cardiff Park Advisors first reported a position in LLY in Q3 2022 and has held it in 17 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Cardiff Park Advisors held 889 shares of Eli Lilly worth $1.03M as of Q3 2026.
  • Cardiff Park Advisors bought 33 Eli Lilly shares in Q3 2026, an estimated $38.9K.
  • Eli Lilly made up 0.07% of Cardiff Park Advisors's portfolio in Q3 2026, its #117 holding.
  • Cardiff Park Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 17 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cardiff Park Advisors's 13F filing for Q3 2026, filed 9 Nov 2026.